Home › Triple-Negative Breast Cancer › California › San Diego
Triple-Negative Breast Cancer clinical trials in San Diego, CA
13 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi away
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi away
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- University of California San Diego, La Jolla · 11 mi away
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Scripps Cancer Center ( Site 0052), La Jolla · 11 mi away
Intratumoral N17350 in Advanced Solid Tumors
RecruitingPhase 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi away
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecruitingPhase 2
- University of California San Diego, La Jolla · 11 mi away
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
RecruitingPhase 1
- UCSD Moores Cancer Center, La Jolla · 11 mi away
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi away
A Beta-only IL-2 ImmunoTherapY Study
RecruitingPhase 1/2
- Sharp Memorial Hospital, San Diego
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RecruitingPhase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer48 studies
- Breast Cancer41 studies
- Cancer (all types)32 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer25 studies
- Ovarian Cancer24 studies
- Pancreatic Cancer24 studies
- Lung Cancer23 studies
- Obesity23 studies
- Heart Failure23 studies
- Depression21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.